Dengue Vaccine Market Poised to Attain Remarkable Growth of USD 1.28 Billion by 2030

This Dengue Vaccine market research report offers numerous advantages that can be applied to various facets of the healthcare industry. It comprehensively addresses the diverse segments essential for today’s business requirements. The report categorizes the market primarily by type, application, and region, providing both regional and global market analyses. Furthermore, this Dengue Vaccine report serves as a validation tool for data gathered through internal or primary research efforts. It offers insights into Compound Annual Growth Rate (CAGR) estimations, market drivers, and market constraints within the healthcare industry, aiding businesses in formulating diverse strategies.

The research conducted within this Dengue Vaccine report facilitates the assessment of critical aspects, including but not limited to investments in emerging markets, the success of new product launches, and the expansion of market share. The strategies outlined encompass a range of activities such as introducing new products, expanding operations, forming agreements, initiating joint ventures, pursuing partnerships, executing acquisitions, and other measures to enhance market presence. Furthermore, the report delves into factors like import/export dynamics, gross margin, pricing, cost structures, and consumption trends. These elements are thoroughly examined within the production, supply, sales, and market status sections. In summary, this report acts as a guiding beacon, directing your attention toward the data and realities pertinent to the industry.

Data Bridge Market Research analyses a growth rate in the dengue vaccine market in the forecast period 2023-2030. The expected CAGR of the dengue vaccine market tends to be around 11.7% in the mentioned forecast period. The market was valued at USD 0.53 billion in 2022, and it would grow up to USD 1.28 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Dengue Vaccine Sample Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dengue-vaccine-market&Aniket

Furthermore, the report provides an in-depth overview of product specifications, technology, product types, and production analysis, taking into consideration important factors like revenue, cost, gross margin, and gross. The Dengue Vaccine market is expected to experience significant growth during the forecast period, driven by increasing demand at the end-user level. According to the market report, the Dengue Vaccine market is set to reach new heights during the projected period.

Key Growth Drivers:

• Increasing Incidence of Dengue

Growing incidence of dengue is projected to boost growth of the dengue vaccine market during the forecast period. For instance, as per the Pan American Health Organization, 1,191,815 cases of dengue were stated, wherein 546,589 were laboratory-confirmed and 5,599 were classified as severe dengue in the region of the Americas, between epidemiological week 1 and 22 of 2019. Thus, this boosts the demand for vaccines.

• Growing R&D Activities

The commitment to R&D for vaccine development is one of the most essential strategies to obtain a competitive edge in the dengue vaccines market. Persistent research holds promising potential for the development of next-gen dengue, malaria, and tuberculosis vaccines. Several R&D of live attenuated vaccines is also expected to help in the growth of the market. For instance, in May 2019, the U.S. FDA approved Dengvaxia used for the prevention of dengue disease is caused by all dengue virus serotypes. It is a live attenuated tetravalent chimeric vaccine which is made using recombinant DNA technology. Additionally, Panacea Biotec, a global generic and specialty pharmaceutical and vaccine maker registered in India, has successfully completed phase I/II study of its novel tetravalent recombinant chimeric dengue candidate vaccine DengiAll.

The report outlines the involvement of key players, including:

• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Novartis AG (Switzerland)
• GSK plc (U.K.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Takeda Pharmaceutical Company Limited (Japan)
• BIO-MED (India)
• Intercept Pharmaceuticals, Inc (U.K.)
• Emcure Pharmaceuticals Limited (India)
• Changchun BCHT Biotechnology Co. (China)

• Novo Medi Sciences (India)

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-dengue-vaccine-market?Aniket

Key Market Segmentation

Type

• Live Attenuated Vaccine
• Chimeric Live Attenuated Vaccine
• Inactivated Vaccine
• Subunit Vaccine
• Nucleic Acid Based Vaccine

Treatment

• Diuretic
• Chlorothiazide
• Chlorthalidone
• Hydrochlorothiazide
• Indapamide
• Anti-Allergic
• Cetirizine
• Desloratadine
• Fexofenadine
• Blood Thinners
• Apixaban
• Dabigatran
• Edoxaban
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

The Dengue Vaccine market report includes the following countries in different regions:

The aforementioned regions provide extensive coverage of key markets, offering a comprehensive global perspective on the market landscape. Let’s take a closer look at the regions and the countries they encompass:

1. North America: Includes the United States, Canada, and Mexico.
2. Europe: Encompasses Germany, France, the United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
3. Asia-Pacific (APAC): Comprises China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, the Philippines, and other Asia-Pacific countries.
4. Middle East and Africa (MEA): Consists of Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
5. South America: Involves Brazil, Argentina, and other countries in South America.

Incorporating these regions into market research is of utmost importance as they represent significant economic and industrial hubs with diverse consumer markets. Analyzing these regions provides businesses with valuable insights into global trends, enabling them to make informed decisions and formulate effective strategies.

Understanding the market dynamics in these regions is essential for companies seeking to cater to the distinct demands and preferences of various regional markets. Whether businesses plan to expand their operations or stay updated with the ever-changing global landscape, this approach ensures they can adapt and tailor their products or services to meet the specific needs of each region. Ultimately, this leads to a more successful and sustainable global presence.

North America has been witnessing positive growth for the dengue vaccine market throughout the forecast period due to the presence of major key players and the increased prevalence of dengue.

Asia-Pacific dominates the market due to increase in government expenditure for development of better healthcare infrastructures within the region.

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Get the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-dengue-vaccine-market&Aniket

Browse More Reports:

Postpartum Depression Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-postpartum-depression-market?AM

Frozen Shoulder Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-frozen-shoulder-market?AM

Acoustic Neuroma Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-acoustic-neuroma-market?AM

Cancer Gene Therapy Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-cancer-gene-therapy-market?AM

Depth of Anesthesia Monitoring Market – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-depth-of-anesthesia-monitoring-market?AM

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com